Epigenetic Regulation of Bone Remodeling and Its Impacts in Osteoporosis

Overview

Journal Int J Mol Sci

Publisher MDPI

Specialties Biochemistry
Chemistry
Molecular Biology

Date 2016 Sep 7

PMID 27598138

Citations 32

Authors

Chafik Ghayor

Franz E Weber

Affiliations

Soon will be listed here.

Abstract

Epigenetics describes mechanisms which control gene expression and cellular processes without changing the DNA sequence. The main mechanisms in epigenetics are DNA methylation in CpG-rich promoters, histone modifications and non-coding RNAs (ncRNAs). DNA methylation modifies the function of the DNA and correlates with gene silencing. Histone modifications including acetylation/deacetylation and phosphorylation act in diverse biological processes such as transcriptional activation/inactivation and DNA repair. Non-coding RNAs play a large part in epigenetic regulation of gene expression in addition to their roles at the transcriptional and post-transcriptional level. Osteoporosis is the most common skeletal disorder, characterized by compromised bone strength and bone micro-architectural deterioration that predisposes the bones to an increased risk of fracture. It is most often caused by an increase in bone resorption that is not sufficiently compensated by a corresponding increase in bone formation. Nowadays it is well accepted that osteoporosis is a multifactorial disorder and there are genetic risk factors for osteoporosis and bone fractures. Here we review emerging evidence that epigenetics contributes to the machinery that can alter DNA structure, gene expression, and cellular differentiation during physiological and pathological bone remodeling.

Citing Articles

The Role of microRNA in the Regulation of Differentiation and the Functionality of Osteoblasts, Osteoclasts, and Their Precursors in Osteoporosis.

Yalaev B, Kaletnik E, Karpova Y, Belaya Z, Minniakhmetov I, Mokrysheva N Noncoding RNA. 2025; 11(1).

PMID: 39997614 PMC: 11858178. DOI: 10.3390/ncrna11010014.

LINC01271 promotes fracture healing via regulating miR-19a-3p/PIK3CA axis.

Chen Q, Huang L, Ji W, Huang M, Sima J, Li J J Orthop Surg Res. 2025; 20(1):33.

PMID: 39794875 PMC: 11724611. DOI: 10.1186/s13018-024-05444-x.

Genistein Supplementation and Bone Health in Breast Cancer in Rats.

Skrajnowska D, Bielecki W, Szterk A, Ofiara K, Bobrowska-Korczak B Nutrients. 2024; 16(6).

PMID: 38542823 PMC: 10974594. DOI: 10.3390/nu16060912.

Dnmt3b ablation affects fracture repair process by regulating apoptosis.

Wang X, Ge Q, Zeng Q, Zou K, Bao Z, Ying J BMC Musculoskelet Disord. 2024; 25(1):180.

PMID: 38413962 PMC: 10900613. DOI: 10.1186/s12891-024-07283-7.

Role of histone modification in the occurrence and development of osteoporosis.

Sun P, Huang T, Huang C, Wang Y, Tang D Front Endocrinol (Lausanne). 2022; 13:964103.

PMID: 36093077 PMC: 9458911. DOI: 10.3389/fendo.2022.964103.

References

Seeliger C, Karpinski K, Haug A, Vester H, Schmitt A, Bauer J . Five freely circulating miRNAs and bone tissue miRNAs are associated with osteoporotic fractures. J Bone Miner Res. 2014; 29(8):1718-28. DOI: 10.1002/jbmr.2175. View

Feinberg A, Tycko B . The history of cancer epigenetics. Nat Rev Cancer. 2004; 4(2):143-53. DOI: 10.1038/nrc1279. View

Sakabe K, Wang Z, Hart G . Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc Natl Acad Sci U S A. 2010; 107(46):19915-20. PMC: 2993388. DOI: 10.1073/pnas.1009023107. View

Jintaridth P, Tungtrongchitr R, Preutthipan S, Mutirangura A . Hypomethylation of Alu elements in post-menopausal women with osteoporosis. PLoS One. 2013; 8(8):e70386. PMC: 3749148. DOI: 10.1371/journal.pone.0070386. View

Baek S . When signaling kinases meet histones and histone modifiers in the nucleus. Mol Cell. 2011; 42(3):274-84. DOI: 10.1016/j.molcel.2011.03.022. View

Dou C, Zhang C, Kang F, Yang X, Jiang H, Bai Y . MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation. Biochim Biophys Acta. 2014; 1839(11):1084-96. DOI: 10.1016/j.bbagrm.2014.08.002. View

Cao Y, Lv Q, Lv C . MicroRNA-153 suppresses the osteogenic differentiation of human mesenchymal stem cells by targeting bone morphogenetic protein receptor type II. Int J Mol Med. 2015; 36(3):760-6. DOI: 10.3892/ijmm.2015.2275. View

Yasui T, Hirose J, Aburatani H, Tanaka S . Epigenetic regulation of osteoclast differentiation. Ann N Y Acad Sci. 2011; 1240:7-13. DOI: 10.1111/j.1749-6632.2011.06245.x. View

Kagiya T, Nakamura S . Expression profiling of microRNAs in RAW264.7 cells treated with a combination of tumor necrosis factor alpha and RANKL during osteoclast differentiation. J Periodontal Res. 2012; 48(3):373-85. DOI: 10.1111/jre.12017. View

10.

Ghayor C, Gjoksi B, Siegenthaler B, Weber F . N-methyl pyrrolidone (NMP) inhibits lipopolysaccharide-induced inflammation by suppressing NF-κB signaling. Inflamm Res. 2015; 64(7):527-36. DOI: 10.1007/s00011-015-0833-x. View

11.

Gjoksi B, Ghayor C, Siegenthaler B, Ruangsawasdi N, Zenobi-Wong M, Weber F . The epigenetically active small chemical N-methyl pyrrolidone (NMP) prevents estrogen depletion induced osteoporosis. Bone. 2015; 78:114-21. DOI: 10.1016/j.bone.2015.05.004. View

12.

Islam R, Bae H, Yoon W, Woo K, Baek J, Kim H . Pin1 regulates osteoclast fusion through suppression of the master regulator of cell fusion DC-STAMP. J Cell Physiol. 2014; 229(12):2166-74. DOI: 10.1002/jcp.24679. View

13.

Fan X, Roy E, Murphy T, Nanes M, Kim S, Pike J . Regulation of RANKL promoter activity is associated with histone remodeling in murine bone stromal cells. J Cell Biochem. 2004; 93(4):807-18. DOI: 10.1002/jcb.20217. View

14.

Ghayor C, Correro R, Lange K, Karfeld-Sulzer L, Gratz K, Weber F . Inhibition of osteoclast differentiation and bone resorption by N-methylpyrrolidone. J Biol Chem. 2011; 286(27):24458-66. PMC: 3129225. DOI: 10.1074/jbc.M111.223297. View

15.

Kim K, Kim J, Kim I, Lee J, Seong S, Park Y . MicroRNA-26a regulates RANKL-induced osteoclast formation. Mol Cells. 2014; 38(1):75-80. PMC: 4314121. DOI: 10.14348/molcells.2015.2241. View

16.

Lee J, Lee Y, Kim M, Choi J, Park E, Kim S . Methylation of the mouse DIx5 and Osx gene promoters regulates cell type-specific gene expression. Mol Cells. 2006; 22(2):182-8. View

17.

Zhao C, Sun W, Zhang P, Ling S, Li Y, Zhao D . miR-214 promotes osteoclastogenesis by targeting Pten/PI3k/Akt pathway. RNA Biol. 2015; 12(3):343-53. PMC: 4615895. DOI: 10.1080/15476286.2015.1017205. View

18.

Delgado-Calle J, Sanudo C, Bolado A, Fernandez A, Arozamena J, Pascual-Carra M . DNA methylation contributes to the regulation of sclerostin expression in human osteocytes. J Bone Miner Res. 2011; 27(4):926-37. DOI: 10.1002/jbmr.1491. View

19.

Huang J, Zhao L, Xing L, Chen D . MicroRNA-204 regulates Runx2 protein expression and mesenchymal progenitor cell differentiation. Stem Cells. 2009; 28(2):357-64. PMC: 2837600. DOI: 10.1002/stem.288. View

20.

Baertschi S, Baur N, Lueders-Lefevre V, Voshol J, Keller H . Class I and IIa histone deacetylases have opposite effects on sclerostin gene regulation. J Biol Chem. 2014; 289(36):24995-5009. PMC: 4155667. DOI: 10.1074/jbc.M114.564997. View